NCT01260896View on ClinicalTrials.gov

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Healthy
Interventions
DRUG

Venlafaxine Hydrochloride

150 mg Extended-Release Capsule

DRUG

Effexor® XR

150 mg Extended-Release Capsule

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01260896 - Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter